Abiopharma

🔍 Weerasinghe Rohan (Director)

Company: PHINIA INC. (PHIN)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | shares_owned_after: 22,686.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Managed Account | shares_owned_after: 12.00
• Acquired 41 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,551.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1

Footnotes:

• F1: Each deferred restricted stock unit ("DRSU") is the economic equivalent of one share of PHINIA Inc. common stock and will vest on the one-year anniversary of the grant date. These DRSUs will settle into an equal number of shares of the issuer's Common Stock, including any additional DRSUs acquired as a result of dividend equivalents that have vested, upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan.
• F2: Represents shares of DRSUs acquired following the automatic reinvestment of dividends on outstanding DRSUs held on the dividend record date, as required by the terms of such award.